LFG
RVMD icon

Larson Financial Group’s Revolution Medicines RVMD Stock Holding History

Larson Financial Group’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39K Buy
208
+104
+100% +$15.2K ﹤0.01% 1638
2026
Q1 		$10.1K Buy
104
+4
+4% +$404 ﹤0.01% 2247
2025
Q4 		$7.96K Buy
+100
New +$6.56K ﹤0.01% 2244
2025
Q2 		– Sell
-51
Closed -$1.8K – 3473
2025
Q1 		$1.8K Buy
51
+25
+96% +$1.01K ﹤0.01% 2198
2024
Q4 		$1.14K Hold
26
– – ﹤0.01% 2011
2024
Q3 		$1.18K Buy
+26
New +$1.13K ﹤0.01% 1955

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Larson Financial Group's RVMD Position: Q2 2026 in Review

Larson Financial Group increased its Revolution Medicines (RVMD) stake by 100% in Q2 2026, buying an estimated $15.2K and bringing the position to 208 shares worth $39K. The position accounts for ﹤0.01% of the portfolio, ranked #1638.

Larson Financial Group first reported a position in RVMD in Q3 2024 and has held it in 6 quarters since. 693 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Larson Financial Group held 208 shares of Revolution Medicines worth $39K as of Q2 2026.
  • Larson Financial Group bought 104 Revolution Medicines shares in Q2 2026, an estimated $15.2K.
  • Revolution Medicines made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #1638 holding.
  • Larson Financial Group first reported a position in Revolution Medicines in Q3 2024 and has held it in 6 quarters since.
  • 693 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.